Pediatric Quality of Life in Transitioning to the Insulin Pump: Does Prior Regimen Make a Difference?

Abstract

A shift in conventional diabetes management has graduated to basal (glargine) and bolus (rapid-acting analogue) therapy via multiple daily injections or continuous subcutaneous insulin infusion (CSII). Continuous subcutaneous insulin infusion is considered the most intensive type of diabetes management, and before transitioning, consideration of regimen benefits should include lifestyle and quality-of-life issues in addition to medical benefits. Short-term and long-term changes in children's quality of life, as a function of their pre-CSII diabetes regimen, was assessed in 52 children before their transition to CSII from a conventional or multiple daily injection regimen. Results demonstrated significant improvement in quality of life only for those children transitioning to CSII from conventional vs multiple daily injection regimens; results were maintained at 6 months following pump initiation. Quality of life is an important consideration as children transition from more traditional to intensive regimens, and CSII devices may not necessarily improve satisfaction with diabetes control in all pediatric patients. Risks and benefits of both intensive regimens should be discussed before making the transition.

Keywords

type 1 diabetes mellitus pump Lantus NPH/regular quality of life insulin regimen

Get full access to this article

View all access options for this article.

References

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.

Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994; 125:177-188.

Boland EA , Grey M. , Oesterle A. , Fredrickson L. , Tamborlane WV Continuous subcutaneous infusion: a new way to lower risk of severe hypoglycemia, improvement, control, and enhanced coping in adolescents with type 1 diabetes . Diabetes Care. 1999;22:1779-1784.

Alemzadeh R. , Ellis JN , Holzum MK , Parton EA , Wyatt DT Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics. 2004 ;114:e91-e95.

Weissberg-Benchell J. , Antisdel-Lomaglio J. , Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003 ;26:1079-1087.

Valenzuela JM , Patino AM , McCullough J. , et al. Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes. J Pediatr Psychol. 2006;31:650-660.

Doyle EA , Weinzimer SA , Steffen AT , Ahern JH , Vincent M. , Tamborlane WV A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care. 2004;27:1554-1558.

Nahata L. Insulin therapy in pediatric patients with type 1 diabetes: continuous subcutaneous insulin infusion versus multiple daily injections. Clin Pediatr. 2006;45: 505-508.

Ingersoll GM , Marrero DG A modified quality-of-life measure for youths: psychometric properties. Diabetes Educ. 1991 ;17:114-118.